We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-9.85%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$11.4M
Cap. Flow
+$8.51M
Cap. Flow %
7.17%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
KALV
KalVista Pharmaceuticals
KALV
+$19M

Top Sells

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$7.97M
2
OCUL icon
Ocular Therapeutix
OCUL
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$66.2M 55.74%
3,489,533
– –
KALV
2
DELISTED
KalVista Pharmaceuticals
KALV
$18.2M 15.36%
+2,579,490
New +$19M
OCUL icon
3
Ocular Therapeutix
OCUL
$2.38B
$13.4M 11.31%
1,605,207
-327,400
-17% -$2.54M
ATXS
4
DELISTED
Astria Therapeutics
ATXS
$10.3M 8.69%
47,628
– –
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$9.81M 8.26%
580,515
– –
EVAR
6
DELISTED
Lombard Medical, Inc.
EVAR
$765K 0.64%
1,275,779
– –
RPTP
7
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-888,132
Closed -$7.97M

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q4 2016 Portfolio in Review

As of Q4 2016, SV Health Investors held 7 positions worth $119M, down 8.8% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $8.51M of net new capital in Q4 2016, opening 1 new position. Its largest new stake was KalVista Pharmaceuticals: 2,579,490 shares worth $18.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 94% a quarter earlier.

On the sell side, the largest reduction was Ocular Therapeutix, an estimated $2.54M trimmed.

  • SV Health Investors's largest Q4 2016 buy was KalVista Pharmaceuticals: 2,579,490 shares worth $18.2M.
  • SV Health Investors's biggest Q4 2016 reduction was Ocular Therapeutix, cutting an estimated $2.54M.
  • SV Health Investors fully exited RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2016, selling an estimated $7.97M.
  • SV Health Investors's ten largest holdings make up 100% of its $119M portfolio in Q4 2016.
  • SV Health Investors opened 1 new position and closed 1 in Q4 2016.
  • SV Health Investors's portfolio value fell 8.8% quarter-over-quarter to $119M.

Based on SV Health Investors's 13F filing for Q4 2016, filed 7 Feb 2017.